00078-0671 TYKERB - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00078-0671

Brand Name:

TYKERB

Generic Name:

Lapatinib

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: LAPATINIB DITOSYLATE

Strength: 250.0

Unit: mg/1

Packages:

Code: 00078-0671-19

Description: 150 TABLET in 1 BOTTLE (0078-0671-19)

Effective Date: Aug. 3, 2016

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

EGFR/HER2

Orphan Drug Designation:

Status:

In Use